Arab World | Immunization, measles (% of children ages 12-23 months)
Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
Arab World
Records
63
Source
Arab World | Immunization, measles (% of children ages 12-23 months)
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
14.74424951 1980
15.92309373 1981
22.64685235 1982
26.07573177 1983
31.64997204 1984
52.73491455 1985
58.18849264 1986
61.95595012 1987
70.53616432 1988
76.38828085 1989
76.99882999 1990
76.55556919 1991
75.31020363 1992
75.96051865 1993
75.50183743 1994
77.1372226 1995
79.65227754 1996
79.27290642 1997
81.75114843 1998
81.94078363 1999
81.88447513 2000
81.42912819 2001
81.48898216 2002
81.70311118 2003
82.32138645 2004
82.49180527 2005
81.98447375 2006
83.44402689 2007
83.0656423 2008
85.47168042 2009
86.88442702 2010
86.9119682 2011
84.0487164 2012
85.16796313 2013
83.91296498 2014
84.00383158 2015
86.24654462 2016
85.68610846 2017
84.60705446 2018
84.73178876 2019
82.64573504 2020
82.21116428 2021
83.01954621 2022
Arab World | Immunization, measles (% of children ages 12-23 months)
Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
Arab World
Records
63
Source